4DMedical Ltd.ASX: 4DX

4DMedical wins $1.9m funding for CT VQ clinical studies

· Issued by 4DMedical Ltd.

Filed with ASX · · 3 pages · English

Summary by 6ix AI

4DMedical Ltd. has announced the receipt of significant funding for clinical studies. This funding aims to generate clinical evidence to facilitate the adoption of CT:VQ as a substitute for traditional nuclear medicine scans. The announcement highlights the potential for CT:VQ technology to disrupt the respiratory diagnostics market.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

4DMedical Ltd. on 6ix

Earlier from 4DMedical

Later from 4DMedical

All 4DMedical news releases